Login to Your Account

Pharma: Other News To Note

Friday, August 30, 2013
Galderma Laboratories LP, of Fort Worth, Texas, said the FDA approved Mirvaso (brimonidine) topical gel 0.33 percent for the topical treatment of the facial erythema of rosacea in adults.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription